Rare drug development cannot move forward, or move forward quickly without collaboration. The ecosystem works best when there are multiple voices and stakeholders at the table – patients, academic and industry researchers, regulatory stakeholders, and physicians.
Should you collaborate with CROs or academic researchers? When do you seek out collaborators? Who do you partner with?
For more information, visit
This video includes interviews that were filmed at the 2023 RARE Drug Development Symposium, May 1-3 in Philadelphia, Pennsylvania. For more information about this event, or to become involved in next year’s event, please visit https://globalgenes.org/event/rare-disease-drug-development/
Stay Connected
Sign up for updates straight to your inbox.